US stocks: US market regains ground as bond yields ease; healthcare stocks rally
Moderna more than doubled after a late-stage cancer therapy trial with Merck cut melanoma recurrence risk, while the S&P 500 healthcare sector hit a record high.
5 Articles
5 Articles
US stocks: US market rises as yields ease, Moderna lifts healthcare stocks
US stock markets enjoyed a boost as easing bond yields and a spike in Moderna shares contributed to a favorable trading environment. Despite the Federal Reserve's minutes highlighting inflation concerns and discussions on rate hikes, investors remained optimistic. The Treasury's announcement of liquidity support revitalized riskier assets, particularly in tech stocks, while the success of Moderna's cancer therapy trial uplifted the healthcare se…
US stocks: US market regains ground as bond yields ease; healthcare stocks rally
Major stock indexes recovered on Wednesday after a prior day's decline. Moderna shares surged significantly following positive cancer therapy trial results. Government bond yields eased from highs, boosting investor risk appetite. Retailers like Target and Lowe's reported quarterly results, influencing consumer spending views. Geopolitical developments and Federal Reserve minutes remained key investor focuses.
Wall Street recovers as yields ease; Moderna lifts healthcare stocks
The main U.S. indexes rebounded on Wednesday after a steep tech selloff in the previous session as easing government bond yields boosted risk appetite, while markets assessed a flood of positive corporate updates including from vaccine-maker Moderna.
Wall Street sees a rebound after measures to curb interest rate volatility, and vaccine cheers lift several healthcare stocks.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
